Close
Help




JOURNAL

Clinical Medicine Insights: Case Reports

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease

Submit a Paper


Clinical Medicine Insights: Case Reports 2011:4 49-52

Case report

Published on 06 Oct 2011

DOI: 10.4137/CCRep.S8150


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Case Reports

Abstract

We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. We subsequently initiated treatment with 25 mg of etanercept, subcutaneously injected twice weekly. Following 6 months of therapy with this agent, sustained improvement in dyspnea, cough was reported by the patient and respiratory function test showed marked improvement. The improvement was confirmed by reduced middle and lower lung markings on chest radiography and high-resolution CT scan. This report suggests etanercept may be effective in the treatment of rheumatoid arthritis-associated interstitial lung disease.



Downloads

PDF  (464.11 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Clinical Medicine Insights: Case Reports
I found Clinical Medicine Insights: Case Reports very, very user friendly.  The entire process is easy and straightforward.  The corresponding author is kept updated on the progress at every point.  I am pleased to send this endorsement.
Dr Adebayo Oyedeji (Lekki Hospital, Nigeria)
More Testimonials

Quick Links


New article and journal news notification services